These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 33200285

  • 21. Use of the wearable cardioverter-defibrillator - the Swiss experience.
    Kovacs B, Reek S, Sticherling C, Schaer B, Linka A, Ammann P, Brenner R, Krasniqi N, Müller AS, Dzemali O, Kobza R, Grebmer C, Haegeli L, Berg J, Mayer K, Schläpfer J, Domenichini G, Reichlin T, Roten L, Burri H, Eriksson U, Saguner AM, Steffel J, Duru F, Swiss Wcd Registry.
    Swiss Med Wkly; 2020 Sep 21; 150():w20343. PubMed ID: 33035354
    [Abstract] [Full Text] [Related]

  • 22. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study.
    Garcia R, Combes N, Defaye P, Narayanan K, Guedon-Moreau L, Boveda S, Blangy H, Bouet J, Briand F, Chevalier P, Cottin Y, Da Costa A, Degand B, Deharo JC, Eschalier R, Extramiana F, Goralski M, Guy-Moyat B, Guyomar Y, Hermida JS, Jourda F, Lellouche N, Mahfoud M, Manenti V, Mansourati J, Martin A, Pasquié JL, Ritter P, Rollin A, Tibi T, Yalioua A, Gras D, Sadoul N, Piot O, Leclercq C, Marijon E.
    Europace; 2021 Jan 27; 23(1):73-81. PubMed ID: 33257972
    [Abstract] [Full Text] [Related]

  • 23. [Patients with a wearable cardioverter-defibrillator (WCD) : Prescription, function and rehabilitation support].
    Schlitt A, Guha M, Noutsias M, Klein HH, Klein HU.
    Herz; 2019 Aug 27; 44(5):379-389. PubMed ID: 29234842
    [Abstract] [Full Text] [Related]

  • 24. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
    Kaspar G, Sanam K, Gholkar G, Bianco NR, Szymkiewicz S, Shah D.
    Int J Cardiol; 2018 Dec 01; 272():179-184. PubMed ID: 30121177
    [Abstract] [Full Text] [Related]

  • 25. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B, Reek S, Saguner AM, Krasniqi N, Eriksson U, Duru F.
    Swiss Med Wkly; 2019 Nov 04; 149():w20136. PubMed ID: 31707723
    [Abstract] [Full Text] [Related]

  • 26. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
    Spar DS, Bianco NR, Knilans TK, Czosek RJ, Anderson JB.
    Circ Arrhythm Electrophysiol; 2018 Jul 04; 11(7):e006163. PubMed ID: 29945928
    [Abstract] [Full Text] [Related]

  • 27. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU, Goldenberg I, Moss AJ.
    Eur Heart J; 2013 Aug 04; 34(29):2230-42. PubMed ID: 23729691
    [Abstract] [Full Text] [Related]

  • 28. Real-world experience with the wearable cardioverter defibrillator: clinical effectiveness and wear-time adherence in patients at high risk for sudden cardiac death.
    Weth C, Abuazab H, Ewen S, Ukena C, Böhm M, Custodis F.
    Herzschrittmacherther Elektrophysiol; 2022 Mar 04; 33(1):55-62. PubMed ID: 34694459
    [Abstract] [Full Text] [Related]

  • 29. Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort.
    Zylla MM, Hillmann HAK, Proctor T, Kieser M, Scholz E, Zitron E, Katus HA, Thomas D.
    Heart Vessels; 2018 Nov 04; 33(11):1390-1402. PubMed ID: 29721674
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Absence of left bundle branch block and blood urea nitrogen predict improvement in left ventricular ejection fraction in patients with cardiomyopathy and wearable cardioverter defibrillators.
    Mehta NA, Abdulsalam N, Kouides R, Ahmed H, Atif R, Shah A, Taylor S, Chuprun D, Huang D, Rao M.
    Clin Cardiol; 2020 Mar 04; 43(3):260-266. PubMed ID: 31860745
    [Abstract] [Full Text] [Related]

  • 32. Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.
    Sasaki S, Shoji Y, Ishida Y, Kinjo T, Tsushima Y, Seno M, Nishizaki F, Itoh T, Izumiyama K, Yokota T, Yokoyama H, Yamada M, Horiuchi D, Kimura M, Higuma T, Tomita H, Okumura K.
    J Cardiol; 2017 Jan 04; 69(1):359-363. PubMed ID: 27595899
    [Abstract] [Full Text] [Related]

  • 33. Age differences of patients treated with wearable cardioverter defibrillator: Data from a multicentre registry.
    El-Battrawy I, Tenbrink D, Kovacs B, Dreher TC, Blockhaus C, Klein N, Shin DI, Hijazi M, Rosenkaimer S, Beiert T, Abumayyaleh M, Saguner AM, Kowitz J, Erath JW, Duru F, Mügge A, Aweimer A, Akin I.
    Eur J Clin Invest; 2023 Jul 04; 53(7):e13977. PubMed ID: 36852491
    [Abstract] [Full Text] [Related]

  • 34. Cost-minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: Clinical and economic implications.
    Boriani G, Mantovani LG, Cortesi PA, De Ponti R, D'Onofrio A, Arena G, Curnis A, Forleo G, Guerra F, Porcu M, Sgarito G, Botto GL.
    Clin Cardiol; 2021 Nov 04; 44(11):1497-1505. PubMed ID: 34427926
    [Abstract] [Full Text] [Related]

  • 35. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.
    Zishiri ET, Williams S, Cronin EM, Blackstone EH, Ellis SG, Roselli EE, Smedira NG, Gillinov AM, Glad JA, Tchou PJ, Szymkiewicz SJ, Chung MK.
    Circ Arrhythm Electrophysiol; 2013 Feb 04; 6(1):117-28. PubMed ID: 23275233
    [Abstract] [Full Text] [Related]

  • 36. ECG as a risk stratification tool in patients with wearable cardioverter-defibrillator.
    Gassanov N, Mutallimov M, Caglayan E, Erdmann E, Er F.
    J Cardiol; 2022 Dec 04; 80(6):573-577. PubMed ID: 35985868
    [Abstract] [Full Text] [Related]

  • 37. Who Should Receive a Wearable Defibrillator Vest at Hospital Discharge?
    Kachur S, Morin DP.
    Curr Cardiol Rep; 2019 Sep 07; 21(10):125. PubMed ID: 31494744
    [Abstract] [Full Text] [Related]

  • 38. Sex differences and adherence of patients treated with wearable cardioverter-defibrillator: Insights from an international multicenter register.
    Abumayyaleh M, Dreher TC, Rosenkaimer S, Röger S, Erath JW, Klein N, Kovacs B, Duru F, Saguner AM, El-Battrawy I, Akin I.
    J Cardiovasc Electrophysiol; 2022 Nov 07; 33(11):2243-2249. PubMed ID: 35930623
    [Abstract] [Full Text] [Related]

  • 39. Extended follow-up after wearable cardioverter-defibrillator period: the PROLONG-II study.
    Mueller-Leisse J, Brunn J, Zormpas C, Hohmann S, Hillmann HAK, Eiringhaus J, Bauersachs J, Veltmann C, Duncker D.
    ESC Heart Fail; 2021 Dec 07; 8(6):5142-5148. PubMed ID: 34480414
    [Abstract] [Full Text] [Related]

  • 40. Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology-A PROLONG-II Substudy.
    Mueller-Leisse J, Brunn J, Zormpas C, Hohmann S, Hillmann HAK, Eiringhaus J, Bauersachs J, Veltmann C, Duncker D.
    Sensors (Basel); 2022 Mar 05; 22(5):. PubMed ID: 35271182
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.